- Home
- PPIH vs PBYI Comparison
PPIH vs PBYI Comparison
Compare PPIH & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPIH
- PBYI
- Stock Information
- Founded
- PPIH 1993
- PBYI 2010
- Country
- PPIH United States
- PBYI United States
- Employees
- PPIH N/A
- PBYI N/A
- Industry
- PPIH Pollution Control Equipment
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- PPIH Industrials
- PBYI Health Care
- Exchange
- PPIH Nasdaq
- PBYI Nasdaq
- Market Cap
- PPIH 187.7M
- PBYI 167.3M
- IPO Year
- PPIH N/A
- PBYI N/A
- Fundamental
- Price
- PPIH $23.09
- PBYI $3.38
- Analyst Decision
- PPIH
- PBYI Strong Buy
- Analyst Count
- PPIH 0
- PBYI 1
- Target Price
- PPIH N/A
- PBYI $7.00
- AVG Volume (30 Days)
- PPIH 71.7K
- PBYI 379.0K
- Earning Date
- PPIH 06-13-2025
- PBYI 07-31-2025
- Dividend Yield
- PPIH N/A
- PBYI N/A
- EPS Growth
- PPIH N/A
- PBYI 143.51
- EPS
- PPIH 1.55
- PBYI 0.77
- Revenue
- PPIH $170,810,000.00
- PBYI $232,709,000.00
- Revenue This Year
- PPIH N/A
- PBYI N/A
- Revenue Next Year
- PPIH N/A
- PBYI N/A
- P/E Ratio
- PPIH $14.80
- PBYI $4.36
- Revenue Growth
- PPIH 9.96
- PBYI 2.68
- 52 Week Low
- PPIH $7.72
- PBYI $2.23
- 52 Week High
- PPIH $24.50
- PBYI $4.13
- Technical
- Relative Strength Index (RSI)
- PPIH 74.51
- PBYI 48.53
- Support Level
- PPIH $21.50
- PBYI $3.25
- Resistance Level
- PPIH $24.47
- PBYI $3.39
- Average True Range (ATR)
- PPIH 1.83
- PBYI 0.15
- MACD
- PPIH 0.64
- PBYI -0.03
- Stochastic Oscillator
- PPIH 93.87
- PBYI 22.22
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.